|
2025
|
P/S
|
Providing healthcare information; Providing medical information; Providing information about heal... |
|
2024
|
Invention
|
Anti-alpha-v-beta-8 integrin antibodies and uses thereof.
The present disclosure provides antibo... |
|
|
Invention
|
Anti-alpha-v-beta-8 integrin antibodies and uses thereof. The present disclosure provides antibod... |
|
2023
|
Invention
|
Cannabinoid receptor 1 antagonists/inverse agonists and uses thereof.
Disclosed herein are compo... |
|
|
Invention
|
Cannabinoid receptor 1 antagonists/inverse agonists and uses thereof. Disclosed herein are compou... |
|
2021
|
Invention
|
Ultrapure tetrahydrocannabinol-11-oic acids.
This application is in the field of medicinal chemi... |
|
2020
|
Invention
|
Cannabinoids and uses thereof. The invention relates to cannabinoid compounds, pharmaceutical com... |
|
|
Invention
|
Compositions of ajulemic acid and uses thereof.
The invention relates to crystalline forms of (6... |
|
|
Invention
|
Compositions of ajulemic acid and uses thereof. RRHH-benzo[c]chromene-9-carboxylic acid (ajulemic... |
|
|
Invention
|
Compositions and methods for attenuating side effects of immune checkpoint inhibitor therapy. Dis... |
|
|
Invention
|
Methods for the treatment of infection.
The invention provides methods for treating an infection... |
|
2019
|
Invention
|
Lipoxin a4 analogs and uses thereof.
The invention relates to (S)-6-((1 R,2E,4E,8E,10S)-11-(4-fl... |
|
|
Invention
|
Lipoxin a4 analogs and uses thereof. REEES444). In particular, the invention features pharmaceuti... |
|
|
Invention
|
Cannabinoids and uses thereof.
The invention relates to cannabinoid compounds, pharmaceutical co... |
|
|
Invention
|
Ultrapure tetrahydrocannabinol-11-oic acids. This application is in the field of medicinal chemis... |
|
2018
|
Invention
|
Methods and compositions relating to ultrapure 5-(1,1-dimethylheptyl)-resorcinol.
The invention ... |
|
|
Invention
|
Methods and compositions relating to ultrapure 5-(1,1-dimethylheptyl)-resorcinol. The invention p... |
|
2017
|
P/S
|
Pharmaceutical products for the treatment of fibrosis and inflammatory diseases, namely, cystic f... |
|
|
Invention
|
Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids.
This invention is... |
|
|
Invention
|
Methods for the treatment of infection. The invention provides methods for treating an infection ... |
|
2016
|
Invention
|
Compositions, dosages, and methods of using tetrahydrocannabinol derivatives.
Dosage forms of c... |
|
|
P/S
|
Pharmaceutical products for the treatment of fibrosis and inflammation diseases, namely, cystic f... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory and fibrotic diseases, namely, cyst... |
|
|
P/S
|
Pharmaceutical preparations. Distribution of medical information. |
|
|
P/S
|
Pharmaceutical products for the treatment of fibrosis and
inflammation. Distribution of medical ... |
|
2015
|
P/S
|
Providing personalized healthcare and medical information in the area of fibrosis and inflammation |
|
|
P/S
|
Pharmaceutical preparations for the treatment of fibrosis and inflammation |
|
|
P/S
|
Distribution of medical information by providing a website featuring information about pharmaceut... |
|
2011
|
Invention
|
Compositions, dosages, and methods of using tetrahydrocannabinol derivatives.
Dosage forms of co... |
|
2009
|
Invention
|
8-tetrahydrocannabinol-11-oic acids. 8-THC-11-oic acids, for treatment of interstitial cystitis i... |
